3341 - 3350 of 9038 Results
Title
Year
-
OPENTitle: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 4Start Page: 972End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70183Citation Count: 0
- Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AI2025RESTRICTEDTitle: Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AIJournal Name: 2025 International Conference on Modeling, Simulation & Intelligent Computing (MoSICom)Publisher: IEEEVol:Issue #:Start Page: 316End Page: 321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/mosicom67153.2025.11398248Citation Count: 0
-
OPENTitle: Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammationJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 132Issue #:Start Page: 106217End Page: 106217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbi.2025.106217Best OA location URL: https://doi.org/10.1016/j.bbi.2025.106217Citation Count: 2
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 128
-
OPENTitle: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient StimuliJournal Name: NeuronPublisher: Elsevier BVVol: 94Issue #: 6Start Page: 1205End Page: 1219.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020Best OA location URL: http://www.cell.com/article/S0896627317304580/pdfCitation Count: 283
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Subspace corrected relevance learning with application in neuroimagingJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 149Issue #:Start Page: 102786End Page: 102786Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.artmed.2024.102786Best OA location URL: https://doi.org/10.1016/j.artmed.2024.102786Citation Count: 8
-
OPENTitle: Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuitsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 523Issue #: 1Start Page: 75End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23666Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4232472Citation Count: 59
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 7
- Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients2017RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 175